BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29324755)

  • 1. HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    Saracino A; Cozzi-Lepri A; Shanyinde M; Ceccherini Silberstein F; Nozza S; Di Biagio A; Cassola G; Bruno G; Capobianchi M; Puoti M; Monno L; d'Arminio Monforte A;
    PLoS One; 2018; 13(1):e0190302. PubMed ID: 29324755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
    Saracino A; Bruno G; Scudeller L; Punzi G; Lagioia A; Ladisa N; Monno L; Angarano G
    J Clin Virol; 2014 Mar; 59(3):167-71. PubMed ID: 24461764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients.
    Abravanel F; Raymond S; Pambrun E; Winnock M; Bonnard P; Sogni P; Trimoulet P; Dabis F; Salmon-Ceron D; Izopet J;
    PLoS One; 2012; 7(11):e50289. PubMed ID: 23226258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the "inflamm-aging" process.
    Saracino A; Monno L; Scudeller L; Bruno G; Ladisa N; Punzi G; Volpe A; Lagioia A; Angarano G
    BMC Infect Dis; 2013 May; 13():220. PubMed ID: 23678991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
    Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
    Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.
    Treviño A; Soriano V; Poveda E; Parra P; Cabezas T; Caballero E; Roc L; Rodríguez C; Eiros JM; Lopez M; De Mendoza C;
    J Antimicrob Chemother; 2014 Aug; 69(8):2191-4. PubMed ID: 24788659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
    Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
    Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.
    Nozza S; Canducci F; Galli L; Cozzi-Lepri A; Capobianchi MR; Ceresola ER; Narciso P; Libertone R; Castelli P; Moioli M; D'Arminio Monforte A; Castagna A;
    J Antimicrob Chemother; 2012 May; 67(5):1224-7. PubMed ID: 22298348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure.
    Rozera G; Abbate I; Giombini E; Castagna A; De Luca A; Ceccherini-Silberstein F; Cozzi Lepri A; Cassola G; Torti C; d'Arminio Monforte A; Ippolito G; Capobianchi MR;
    J Antimicrob Chemother; 2014 Nov; 69(11):3085-94. PubMed ID: 25015667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection.
    Basso M; Zago D; Scaggiante R; Cavinato S; Pozzetto I; Stagni C; Parisatto B; Cattelan AM; Battagin G; Sarmati L; Parisi SG
    Sci Rep; 2021 Apr; 11(1):9274. PubMed ID: 33927306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of R5 and X4 HIV variants in antiretroviral treatment experienced patients with virologic failure.
    Ferrer P; Tello M; Montecinos L; Tordecilla R; Rodríguez C; Beltrán C; Guzmán MA; Ferrés M; Pérez CM; Afani A
    J Clin Virol; 2014 Jul; 60(3):290-4. PubMed ID: 24793966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C; Charpentier C; Flandre P; Nino C; Carcelain G; Simon A; Katlama C; Landman R; Brun-Vézinet F; Descamps D; Calvez V; Marcelin AG
    J Med Virol; 2012 Dec; 84(12):1853-6. PubMed ID: 23080487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of coreceptor tropism in PBMC samples from HIV-1 recently infected blood donors by massively parallel sequencing: the REDS II study.
    Pessôa R; Sabino EC; Sanabani SS
    Virol J; 2015 May; 12():74. PubMed ID: 25966986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.
    Briz V; García D; Méndez-Lagares G; Ruiz-Mateos E; de Mulder M; Moreno-Pérez D; Navarro ML; León-Leal JA; de José MI; Ramos JT; Mellado MJ; González-Tomé MI; Leal M; Muñoz-Fernández MA
    Pediatr Infect Dis J; 2012 Oct; 31(10):1048-52. PubMed ID: 22828644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy.
    Di Biagio A; Parisini A; Bruzzone B; Prinapori R; Lauriola M; Paolucci S; Signori A; Barresi R; Icardi G; Calderisi S; Meini G; Dentone C; Cenderello G; Guerra M; Maccabruni A; Rusconi S; Viscoli C
    HIV Clin Trials; 2014; 15(1):45-50. PubMed ID: 24518213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X4 Tropic Virus Prediction Is Associated with a Nadir CD4 T-Cell Count below 100 Cells/mm.
    Sechet M; Roussel C; Schmit JL; Saroufim C; Ghomari K; Merrien D; Cordier F; Pik JJ; Landgraf N; Douadi Y; Liné D; Duverlie G; Castelain S
    Intervirology; 2015; 58(3):155-9. PubMed ID: 25997386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.